TLX2 and ischemia: The presence of the reverse NCX inhibitor KB-R7943 [41] at a concentration of 10 μM significantly reduced the effects of ischemia on striatal (Fig. 4a, b) and cortical (Fig. 5) slice preparations, as determined by measuring the resting release levels of [3H]DA and [3H]NA.